Takeda Pharmaceutical Company Limited (TAK)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | — |
|
| Audit Information | — |
|
| Statements | ||
| Consolidated Statements of Profit Or Loss | — |
|
| Consolidated Statements of Comprehensive Income | — |
|
| Consolidated Statements of Financial Position | — |
|
| Consolidated Statements of Changes In Equity | — |
|
| Consolidated Statements of Cash Flows | — |
|
| Notes | ||
| Assets and Disposal Groups Held For Sale | — |
|
| Basis of Preparation | — |
|
| Bonds and Loans | — |
|
| Business Combinations | — |
|
| Cash and Cash Equivalents | — |
|
| Collaborations, Licensing Arrangements, and Other Asset Acquisitions | — |
|
| Collaborations, Licensing Arrangements, Other Asset Acquisitions, and Others | — |
|
| Commitments and Contingent Liabilities | — |
|
| Cybersecurity Risk Management and Strategy Disclosure | — |
|
| Earnings Per Share | — |
|
| Employee Benefits | — |
|
| Equity and Other Equity Items | — |
|
| Finance Income and Expenses | — |
|
| Financial Instruments | — |
|
| Goodwill | — |
|
| Income Taxes | — |
|
| Insider Trading Policies and Procedures | — |
|
| Intangible Assets | — |
|
| Inventories | — |
|
| Investments Accounted For Using The Equity Method | — |
|
| Material Accounting Policies | — |
|
| Operating Segment and Revenue Information | — |
|
| Other Comprehensive Income (loss) | — |
|
| Other Financial Assets | — |
|
| Other Financial Liabilities | — |
|
| Other Liabilities | — |
|
| Other Operating Income and Expenses | — |
|
| Property, Plant and Equipment | — |
|
| Provisions | — |
|
| Related Party Transactions | — |
|
| Reporting Entity | — |
|
| Share-based Payments | — |
|
| Subsequent Events | — |
|
| Subsidiaries and Associates | — |
|
| Trade and Other Payables | — |
|
| Trade and Other Receivables | — |
|